Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "Arbovirus Testing Market Size, Share & Trends Analysis Report by Type (ELISA-Based Tests, RT-PCR Based Tests), End-use (Diagnostic Laboratories, Hospitals, Research Centers), Region, with Growth Forecasts, 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The Arbovirus Testing Market was valued at USD 1.12 Billion in 2024, and is projected to reach USD 1.43 Billion by 2030, rising at a CAGR of 4.50%
The rising incidence of arboviral diseases such as Zika, dengue, and West Nile is fueling the demand for robust testing solutions. The increasing prevalence of these diseases in various regions has heightened the need for accurate diagnostics to manage outbreaks effectively. Increased awareness among the public and healthcare systems has led to improved surveillance efforts, enabling faster identification and response to potential outbreaks. 
This greater focus on disease monitoring drives the arbovirus testing market, as governments and health organizations prioritize timely detection to control the spread of these infections.
Arbovirus testing has emerged as a pivotal tool in preventing the spread of these Neglected Tropical Diseases (NTDs). According to WHO estimates, around one-fifth of the population-about 1.7 billion people, mostly in developing and low-income nations-must receive diagnosis and treatment for at least one noncommunicable disease annually.
The dengue and chikungunya NTD epidemic impacted almost 40% of Africa. These illnesses are more common in impoverished communities in tropical and hard-to-reach locations due to a favorable environment for virus growth and lack of hygiene. Thus, most NTD cases are reported from Brazil, Yemen, India, Bangladesh, China and several countries in Central and East Africa. Thus, the rising incidence of dengue and chikungunya is anticipated to fuel the demand for arbovirus testing, thereby driving market growth.
Moreover, several international organizations run programs to raise awareness of NTDs, including the United States Global Health Initiative, the Global NTD Program by the Centers for Disease Control and Prevention, the World Health Organization's Global NTD Programs, and the NTD Program by the United States Agency for International Development. These programs focus mainly on reducing or eliminating NTDs such as dengue and chikungunya. In addition, the WHO introduced a pilot program for a WHO Expert Review Panel for Diagnostic Products (ERPD) for NTDs in October 2023. This program focuses on enhancing the quality control and availability of NTD diagnostic tools for medical professionals.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 110 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $1.12 Billion |
| Forecasted Market Value (USD) by 2030 | $1.43 Billion |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | Global |
Arbovirus Testing Market Variables, Trends, & Scope
- Market Lineage Outlook
- Parent Market Outlook
- Related/Ancillary Market Outlook
- Market Dynamics
- Market Driver Analysis
- Market Restraint Analysis
- Arbovirus Testing Market Analysis Tools
- Industry Analysis - Porter's Five Forces Analysis
- PESTLE Analysis
Competitive Landscape
- Abbott
- Thermo Fisher Scientific Inc.
- NovaTec Immundiagnostica GmbH (Gold Standard Diagnostics Frankfurt GmbH)
- Agilent Technologies, Inc.
- EUROIMMUN Medical Laboratory Diagnostics AG
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- QIAGEN
- Bio-Rad Laboratories, Inc.
Global Arbovirus Testing Market Report: Segmentation
Type Outlook (Revenue, USD Million, 2018-2030)
- ELISA-based Tests
- RT-PCR Based Tests
- Other Test Types
End Use Outlook (Revenue, USD Million, 2018-2030)
- Diagnostic Laboratories
- Hospitals
- Research Centers
- Other End Use
Regional Outlook (Revenue, USD Million, 2018-2030)
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/dgtq7i
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
